Serum CRP Is a Better Early Marker for Response to Infliximab Induction Therapy Than Fecal Calprotectin in Patients With Moderate to Severe Ulcerative Colitis

被引：0
|
作者：
Brandse, Johannan F.
Jansen, Jeroen M.
Baars, Paul A.
Lowenberg, M.
Ponsioen, Cyriel
van den Brink, Gijs R.
D'Haens, Geert R.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
212
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
  • [11] Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study
    Drabik, Attyla
    Sturm, Andreas
    Bloemacher, Margit
    Helwig, Ulf
    JMIR RESEARCH PROTOCOLS, 2016, 5 (02):
  • [12] SERUM MARKER PANEL FOR EARLY DETECTION OF ENDOSCOPIC HEALING WITH INFLIXIMAB IN PATIENTS WITH ULCERATIVE COLITIS
    de Bruyn, Magali
    Ringold, Randy
    Ferrante, Marc
    Van Assche, Gert A.
    Opdenakker, Ghislain
    Dukler, Avi
    Vermeire, Severine
    GASTROENTEROLOGY, 2017, 152 (05) : S768 - S768
  • [13] Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis
    Singh, Arshdeep
    Mahajan, Ramit
    Kahlon, Bhavjeet Kaur
    Dhaliwal, Ashvin Singh
    Midha, Vandana
    Mehta, Varun
    Bansal, Namita
    Singh, Dharmatma
    Sood, Ajit
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (04) : 389 - 396
  • [14] Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis
    Arshdeep Singh
    Ramit Mahajan
    Bhavjeet Kaur Kahlon
    Ashvin Singh Dhaliwal
    Vandana Midha
    Varun Mehta
    Namita Bansal
    Dharmatma Singh
    Ajit Sood
    Indian Journal of Gastroenterology, 2022, 41 : 389 - 396
  • [15] Can infliximab induction therapy prevent colectomy in moderate to severe steroid non responsive ulcerative colitis?
    Kordian, T.
    Rees, V.
    Mulanga, X.
    Rogge, C.
    Lee, T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 107 - 107
  • [16] Intestinal ultrasonography accuracy in the evaluation of patients with moderate to severe ulcerative colitis starting infliximab therapy
    Albshesh, A.
    Melnik, P.
    Dotan, A.
    Lahat, A.
    Ungar, B.
    Ben-Horin, S.
    Carter, D.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1301 - I1301
  • [17] Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis
    Ungar, B.
    Mazor, Y.
    Weisshof, R.
    Yanai, H.
    Ron, Y.
    Goren, I.
    Waizbard, A.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Loebstein, R.
    Kopylov, U.
    Dotan, I.
    Chowers, Y.
    Eliakim, R.
    Ben-Horin, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (12) : 1293 - 1299
  • [18] Predictors of early response to infliximab in patients with ulcerative colitis
    Ferrante, Marc
    Vermeire, Severine
    Katsanos, Konstantinos H.
    Noman, Maja
    Van Assche, Gert
    Schnitzler, Fabian
    Arijs, Ingrid
    De Hertogh, Gert
    Hoffman, Ilse
    Geboes, Karel
    Rutgeerts, Paul
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (02) : 123 - 128
  • [19] Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy
    Engstrom, Johanna
    Lonnkvist, Maria
    Befrits, Ragnar
    Ljung, Tryggve
    Diaz-Tartera, Hetzel
    Holst, Mikael
    Hellstrom, Per M.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (09) : 1081 - 1088
  • [20] Correlation of Fecal Calprotectin With Acute Phase Reactants (ESR, CRP) in Mexican Patients With Ulcerative Colitis
    Jesus, Yamamoto
    Laura, Olivares
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S14 - S15
12345